Economic Impact of Adhering to Care Guidelines for Non-surgical Spine Care: The Spinal Frontier
Methods: We utilized data from a US commercial insurer to identify non-surgical SRD episodes of care. Primary Spine Providers (PSP) were categorized on adherence to care guidelines and three comparison groups were created: providers meeting the criteria in 100% of their episodes (PSP 1), providers meeting the criteria in 50-99% of their episodes (PSP 2), and providers meeting the criteria in under 50% of their episodes (PSP 3). Propensity score matching was employed to separately match episodes associated with PSP 1 providers to episodes of PSP 2 and PSP 3 providers. Episode costs between the two sets of matched cohorts was compared using generalized linear models.
Results: There were statistically significant savings of $31.89 per episode for PSP 1 over PSP 2 providers and savings of $61.69 per episode when comparing PSP 1 to PSP 3 providers, representing a 5% and 8% per-episode savings.
Conclusion: These findings suggest that members with non-surgical spine disorders who are treated by providers that consistently follow recommended guidelines have lower episode costs than those treated by less adherent providers.
Learning Areas:Biostatistics, economics
Conduct evaluation related to programs, research, and other areas of practice
Analyze cost differences between primary spine providers who follow or do not follow care guidelines recommended for non-surgical spine-related disorders. Evaluate economic impact of following recommended guidelines for low back pain.
Keyword(s): Chiropractic, Performance Measurement
Qualified on the content I am responsible for because: Data analysis and statistical interpretation. I have over ten years experience in healthcare analytics and medical informatics.
Any relevant financial relationships? Yes
|Name of Organization||Clinical/Research Area||Type of relationship|
|Optum||Healthcare Analytics||Employment (includes retainer)|
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.